Entity Registrant Name Entity Registrant Name Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Lease liabilities Operating Lease, Liability, Noncurrent Statement of Financial Position [Abstract] Cash and cash equivalents Cash and Cash Equivalent Governmental grant receivable Grants Receivable Inventories FIFO Inventory Amount TOTAL CURRENT LIABILITIES Liabilities, Current TOTAL LIABILITIES Liabilities CURRENT ASSETS: Assets, Current [Abstract] Short-term bank deposits Deposits Assets, Current Other receivables and prepaid expenses Prepaid Expense and Other Assets, Current TOTAL CURRENT ASSETS Assets, Current Right-of-use assets Operating Lease, Right-of-Use Asset TOTAL NON-CURRENT ASSETS Assets, Noncurrent Ordinary shares no par value: Authorized 500,000,000 as of June 30, 2026 and December 31, 2025; issued and outstanding 2,205,378 shares as of June 30, 2026 and 960,934 shares as of December 31, 2025 Common Stock, Value, Issued Accumulated losses Accumulated losses Retained Earnings (Accumulated Deficit) TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity NON-CURRENT ASSETS: Assets, Noncurrent [Abstract] Property and equipment, net Property, Plant and Equipment, Net TOTAL ASSETS Assets Accounts payables Accounts Payable, Current Accrued expenses Accrued Liabilities, Current Additional paid-in capital Additional Paid in Capital, Common Stock TOTAL SHAREHOLDERS’ EQUITY Balance Total stockholders equity Balance Equity, Attributable to Parent CURRENT LIABILITIES: Liabilities, Current [Abstract] Accrued payroll and other employment related accruals Employee-related Liabilities, Current Lease liabilities Operating Lease, Liability, Current Issuance of ordinary shares upon vesting of RSUs Stock Issued During Period, Value, Restricted Stock Award, Gross Issuance of ordinary shares upon vesting of RSUs (in Shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Issuance of ordinary shares associated with warrant exercise inducement transaction previously held in abeyance (see note 4.a) Stock Issued During Period of Value Issuance of Ordinary Shares Associated with Warrant Exercise Inducement Transaction Previously Held in Abeyance Value of stock issued issuance of ordinary shares associated with warrant exercise inducement transaction previously held in abeyance. Issuance of ordinary shares associated with warrant exercise inducement transaction previously held in abeyance (see note 4.a) (in Shares) Stock Issued During Period of Shares Issuance of ordinary shares associated with warrant exercise inducement transaction previously held in abeyance Number of issuance of ordinary shares associated with warrant exercise inducement transaction previously held in abeyance. Issuance of ordinary shares for the reverse share split process Stock Issued During Period Of Value Issuance Of Ordinary Shares For The Reverse Share Split Process Amount of issuance of ordinary shares for the reverse share split process. Additional paid-in capital Additional Paid-in Capital [Member] Issuance of ordinary shares and pre-funded warrants associated with best efforts equity offering (see note 4.a) (in Shares) Issuance Of Ordinary Shares And Prefunded Warrants Associated With Bestefforts Offerings Share amount of issuance of ordinary shares and pre-funded warrants associated with best-efforts offering. Issuance of ordinary shares for the reverse share split process (in Shares) Issuance Of Ordinary Shares For The Reverse Split Process Round up in the number of shares during the period as a result of a reverse stock split. Issuance of ordinary shares associated with warrant exercise inducement transaction (see note 4.a) (in Shares) Issuance Of Shares Associated With Warrant Exercise Inducement Transaction Issuance of shares associated with warrant exercise inducement transaction. Issuance of ordinary shares and pre-funded warrants associated with best efforts equity offering (see note 4.a) Issuance Of Ordinary Shares And Prefunded Warrants Associated With Bestefforts Offering Represent the value of issuance of shares associated with best efforts offering. Issuance of ordinary shares associated with warrant exercise inducement transaction (see note 4.a) Issuance Of Shares Associated With Warrant Exercise Inducement Transactions Represent the value of issuance of shares associated with exercise of warrants under warrant inducement agreement. Share-based compensation Share-based compensation expenses Share-Based Payment Arrangement, Noncash Expense Issuance of ordinary shares from an exercise of options and upon vesting of restricted share units (“RSUs”) (in Shares) Issuance Of Ordinary Shares From An Exercise Of Options And Upon Vesting Of Restricted Stock Unit Share amount of issuance of ordinary shares from an exercise of options and upon vesting of restricted stock unit. Balance (in Shares) Balance (in Shares) Shares, Outstanding Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent FINANCING INCOME, NET Financing Income (Expenses), Net Represents the amount of financing income (expenses), net. Issuance of ordinary shares under registered direct offering Stock Issued During Period Value Issuance of Ordinary Shares Under Registered Direct Offering Represent the net amount proceeds from Issuance of ordinary shares under registered direct offering. Issuance of ordinary shares under registered direct offering (in Shares) Stock Issued During Period Shares Issuance of Ordinary Shares Under Registered Direct Offering Represent the Issuance of ordinary shares under registered direct offering. Ordinary shares, authorized Common Stock, Shares Authorized Ordinary shares, share outstanding Outstanding as of December 31, 2025 Outstanding as of June 30, 2026 Common Stock, Shares, Outstanding Income Statement [Abstract] Expenses: Operating Costs and Expenses [Abstract] Impairment of product sales inventory Production Related Impairments or Charges Sales and marketing expenses Selling and Marketing Expense OPERATING LOSS Operating Income (Loss) LOSS BEFORE TAXES Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Interest received from deposits Interest Received From Deposits Represent the amount of interest received from deposits General [Abstract] BASIS FOR PREPARATION Basis of Presentation and Significant Accounting Policies [Text Block] Related Parties [Abstract] EQUITY Shareholders' Equity and Share-Based Payments [Text Block] Subsequent Events [Abstract] Schedule of Share Capital Schedule of Stockholders Equity [Table Text Block] Schedule of Option Activity Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Provision for inventory write-off Inventory Write-down Changes in operating assets and liabilities items: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Decrease in accounts receivables Increase (Decrease) in Accounts Receivable Increase (decrease) in accounts payable Increase (Decrease) in Accounts Payable Decrease in accrued expenses Increase (Decrease) in Accrued Liabilities CASH FLOWS FROM INVESTING ACTIVITIES: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Proceeds from issuance of ordinary shares under inducement offer letter agreement Proceeds From Issuance Of Ordinary Shares Under Inducement Offer Letter Agreement Amount of proceeds from issuance of ordinary shares under inducement offer letter agreement. Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS AT END OF PERIOD Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Equity [Abstract] Schedule of Equity Warrants to Investors and Associate Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block] Schedule of Options to Consultants Schedule Of Options To Consultants Table Text Block Tabular disclosure of stock options issued to consultants. CASH FLOWS FROM OPERATING ACTIVITIES: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Adjustments required to reconcile net loss to net cash used in operating activities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Accrued interest on deposits Accrued Interest On Deposits Represent the amount of changes in accrued interest on deposit. Decrease in inventory Increase (Decrease) in Inventories Decrease (increase) in governmental grants receivables Increase Decrease In Governmental Grants Receivables Amount of decrease(increase) in governmental grants receivables. Decrease in advance payments Increase Decrease In Advance Payments The increase (decrease) during the reporting period in advance payments. Increase in accrued payroll and other employment related accruals Increase (Decrease) in Employee Related Liabilities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation NET DECREASE IN CASH AND CASH EQUIVALENTS Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Equity Components [Axis] Common Stock [Member] Ordinary shares Common Stock [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Consecutive business days Consecutive Business Days Consecutive business days. Ordinary shares issued (in Shares) Issuance Of Shares Associated With Standby Equity Purchase Agreement Number of ordinary shares issued in 2024 associated with the SEPA. Initial pre-paid advance Prepaid Advance Received Carrying value as of the balance sheet date of the debt due within one year. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. Statement of Cash Flows [Abstract] Net loss NET LOSS AND TOTAL COMPREHENSIVE LOSS Net Income (Loss) Attributable to Parent Depreciation Depreciation Investments in short-term deposits ProceedsFromInvestmentsInShorttermDeposits The cash inflow from a investments In short term deposits. Maturities of short-term deposits Proceeds From Maturities Of Short Term Deposits The cash inflow from a maturities of short term deposits. Gross proceed from exercise of warrants The cash inflow associated with the amount received from holders exercising their stock warrants in a warrant inducement agreement. Repayment of convertible promissory note Repayment of Convertible Promissory Note The cash outflow from the repayment of a short-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. Award Type [Domain] Award Date [Domain] Exercise ratio Share Based Compensation Arrangement By Share Based Payment Exercise Ratio Description of exercise ratio. Notes Share Based Compensation Arrangement Notes Description of Notes. Schedule of Option Activity [Abstract] Award Type [Axis] Schedule of Option Activity [Line Items] Schedule of Options Activity [Line Items] Related and Nonrelated Parties [Axis] Asher Dahan [Member] Asher Dahan Member Sale of Stock [Axis] IPO [Member] IPO [Member] Private Placement [Member] Private Placement [Member] Statistical Measurement [Domain] Minimum [Member] Minimum [Member] Plan Name [Domain] 2024 Global Equity Incentive Plan [Member] Two Thousand Twenty Four Global Equity Incentive Plan Member Class of Warrant or Right [Axis] Pre Funded Warrants [Member] Pre Funded Warrants Member Subsequent Event Type [Axis] Subsequent [Member] Subsequent Event [Member] Issued and sold ordinary shares Issued And Sold Connection With Closing IPO Number of units issued and sold in connection with the closing of the IPO. Warrants ordinary shares Class of Warrant or Right, Outstanding Issued and sold ordinary shares Stock Issued During Period, Shares, New Issues Equity - Schedule of Equity Warrants to Investors and Associated [Table] Equity - Schedule of Equity Warrants to Investors and Associate (Details) [Table] September 13, 2022 [Member] September Thirteen Two Thousand Twenty Two Member September 15, 2022 [Member] September Fifteen Two Thousand Twenty Two One Member Schedule of Equity Warrants to Investors and Associated with the IPO [Line Items] Schedule of Options to Consultants [Abstract] Exercise price | $ / shares Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Weighted-average exercise price, Expired and forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted-average exercise price, Outstanding balance Exercise price (in Dollars per share) Weighted-average exercise price, balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-average exercise price, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Schedule of Options To Consultants [Abstract] Ordinary shares price issued (in Dollars per share) Ordinary Shares Price Issued Combined purchase price per Ordinary Share and accompanying warrants in the November 27, 2024 registered direct offering and concurrent private placement. Number of ordinary shares reserved under incentive plan Share Based Compensation Arrangement By Share Based Payment Award Number Of Ordinary Shares Issued Under Incentive Plan Number of Ordinary Shares initially reserved for issuance under the 2024 Global Equity Incentive Plan as of August 2024 Statistical Measurement [Axis] Maximum [Member] Maximum [Member] Exercisable term Exercisable term. Number of warrants issued Warrants Issued During The Period Number of warrants issued On October 29, 2025. Schedule of Share Capital [Abstract] Schedule Of Equity Warrants To Investors And Associated [Abstract] Weighted-average exercise price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Amended exercise price per unit of warrants Amended exercise price per unit of warrants. Number of ordinary shares issued upon the exercise of the August new warrants Number of Ordinary Shares issued upon the exercise of the August New Warrants Number of ordinary shares issued upon the exercise of the august new warrants. Number of august new warrants exercised for cash inducement letter agreement Number of August New Warrants exercised for cash pursuant to the November 29, 2025 inducement letter agreement. Exercise price per ordinary of the august new warrants exercised share Exercise price per Ordinary Share of the August New Warrants exercised pursuant to the November 29, 2025, inducement letter agreement. Granted shares Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Option expenses (in Dollars) Options Expenses The amount share-based compensation expenses. Subsequent Events (Details) [Table] Subsequent Event Type [Domain] Subsequent Events [Line Items] Exercise price (in Dollars per share) Exercise price range (in Dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Number of Options, balance Number of Options, Outstanding balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Number of Options, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of Options, Expired and forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Expiration date Share Based Compensation Arrangement By Share Based Payment Expiration Date Description of Expiration date . Aggregate principal amount Aggregate principal amount An aggregate principal amount of not less than $12.0 million in debt financing. Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Information [Line Items] Document Information [Table] Document Period End Date Document Period End Date Document Type Document Type Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Net loss per ordinary share, diluted (in Dollars per share) Earning Per Share Diluted The amount of net income (loss) for the period available to each share of common stock and pre-funded warrants or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Weighted average number of ordinary shares outstanding diluted (in Shares) Weighted Average Number Of Diluted Share Outstanding The average number of shares and pre-funded warrants or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Statement of Stockholders' Equity [Abstract] Accumulated losses Retained Earnings [Member] Statement [Line Items] Issuance of ordinary shares from an exercise of options and upon vesting of restricted share units (“RSUs”) Issuance Of Ordinary Shares From An Exercise Of Options And Upon Vesting Of Restricted Stock Units Issuance of ordinary shares from an exercise of options and upon vesting of restricted stock units. SHAREHOLDERS’ EQUITY Equity, Attributable to Parent [Abstract] Ordinary shares, par value Common Stock, No Par Value Ordinary shares, share issued Common Stock, Shares, Issued Revenues Revenues Cost of revenues Cost, Direct Material Research and development, net Research And Development Net The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. General and administrative expenses General and Administrative Expense Tax expenses Income Tax Expense (Benefit) Net loss per ordinary share, basic (in Dollars per share) Earning Per Share Basic The amount of net income (loss) for the period per each share of common stock and pre funded warrants or unit outstanding during the reporting period. Weighted average number of ordinary shares outstanding basic (in Shares) Weighted Average Number Of Share Outstanding Basic Number of [basic] shares and pre-funded warrants or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Statement [Table] Equity Component [Domain] Advance payments Advance Payments It represent advances from customers. General (Details) [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement Member General [Line Items] Stockholders equity requirement Stockholders Equity Requirement By Stock Exchanges Represent the minimum amount of stockholders equity requirement by stock exchanges. Net proceeds Net Proceeds From Secondary Entitys First And Second Offering The cash inflow associated with proceeds received from the issuance and sale of the entity’s equity securities in public and other financing transactions. Net proceeds from IPO Net Proceeds From Issuance Of Ordinary Shares Associated With SEPA Net proceeds from IPO. Direct offering and raised net proceeds Direct Offering And Raised Net Proceeds Repesent the amount from registered direct offering and raised net proceeds. Share-based payment expenses for the three co-founders together Share-Based Payment Arrangement, Expense Compliance period compliance period The days of compliance period. Additional compliance period Additional Compliance Period The days of additional compliance period. Related and Nonrelated Parties [Domain] Investment, Name [Axis] Aggregate net proceeds Aggregate Net Proceeds Represent the amount of aggregate net proceeds from issuance of ordinary shares in 2025. Investment, Name [Domain] Related Parties [Line Items] Proceeds from issuance of ordinary shares associated with best-efforts offering Proceeds From Issuance of Ordinary Shares Associated with Best-Efforts Offering Represent the amount of proceeds from issuance of shares issued in the best-efforts offering, net of issuance cost. Decrease in other receivables and prepaid expenses Decrease (Increase) in Other Receivables and Prepaid Expenses Decrease (increase) in other receivables and prepaid expenses. Represent the minimum bid price requirement of the NASDAQ The closing bid price of ordinary share for the previous 30 days before October 24, 2023 SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Supplemental Cash Flow Elements [Abstract] GENERAL Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis for Preparation [Abstract] RELATED PARTIES Related Party Transactions Disclosure [Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] 2017 [Member] Two Thousand Seventeen Member 2023 [Member] Two Thousand Twenty Three Member In connection with Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms Issued over-allotment options Stock Issued During Period Overallotment Options Number of over-allotment options issued to the underwriter in the IPO. Net proceeds from issuance of ordinary shares (in Dollars) Net Proceeds From Issuance Of Ordinary Shares The cash inflow associated with proceeds received from the issuance and sale of the entity’s equity securities in public and other financing transactions. Derivative measurement input Derivative Asset, Measurement Input Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Option Volatility [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Term [Member] Measurement Input, Expected Dividend Rate [Member] Issuance of ordinary shares associated with warrant exercise inducement transaction previously held in abeyance Issuance of ordinary shares associated with warrant exercise inducement transaction previously held in abeyance Issuance of Ordinary Shares for the reverse split process Issuance of Ordinary Shares for the reverse split proces Issuance of Ordinary Shares for the reverse split proces Issuance of Ordinary Shares associated with warrant exercise inducement transaction Issuance of Ordinary Shares associated with warrant exercise inducement transaction. Issuance of Ordinary Shares upon vesting of RSUs Issuance of Ordinary Shares upon vesting of RSUs. Issuance of Ordinary Shares Number of issuance of ordinary shares. Registered Direct Offerings [Member] Equity - Schedule of Option Activity [Table] Equity - Schedule of Option Activity (Details) [Table] Stock Options [Member] Share-Based Payment Arrangement, Option [Member] Related Parties (Details) [Table] Co-Founders [Member] Cofounders Member Equity [Table] Equity (Details) [Table] Sale of Stock [Domain] Over-Allotment Option [Member] Over-Allotment Option [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Plan Name [Axis] 2024 Employee Stock Purchase Plan [Member] Two Thousand Twenty Fous Employee Stock Purchase Plan Member Class of Warrant or Right [Domain] Warrant [Member] Warrant [Member] Equity [Line Items] Number of ordinary shares Number Of Ordinary Shares Number of ordinary shares in each unit that issued in connection with the IPO. Award Date [Axis] September 15, 2022 [Member] September Fifteen Two Thousand Twenty Two Member April 21, 2026 [Member] April Thirty Two Thousand Twenty Five Member Number of Options, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Equity - Schedule of Options to Consultants [Table] Equity - Schedule of Options to Consultants (Details) [Table] 2015 [Member] Two Thousand Fifteen Member 2021 [Member] Two Thousand Twentyone Member No. of options issued Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period No. of options exercisable Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Number of warrants Number Of Warrants Number of warrants. Warrants to purchase Class Of Warrant Or Right Warrants From Exercise Of Overallotment Options Number of warrants from exercise of over-allotment options issued to the underwriter in the IPO. Combined purchase price per share (in Dollars per share) Combined Purchase Price Per Share Combined purchase price per share. Exercise price per share (in Dollars per share) Exercise Price Per Share Exercise price per Ordinary Share of the August New Warrants exercised pursuant to the November 29, 2025, inducement letter agreement Proceed amount (in Dollars) Proceeds from Issuance of Private Placement Offering price per share (in Dollars per share) Class Of Warrant Or Right Offering Price Per Share Offering price per share. Ordinary shares reserved for future issuance Common Stock, Capital Shares Reserved for Future Issuance Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vested shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Sale of Stock, Price Per Share Number of shares issued in connection with registered direct offerings Number of shares issued in connection with registered direct offerings. Number of options to purchase Ordinary Shares granted by the Company Number of options to purchase Ordinary Shares granted by the Company. August New Warrants [Member] Number of pre-funded warrants issued Number of pre-funded warrants issued in the November 27, 2024 registered direct offering. Number of Share Issued Number of Share Issued. Net proceed from warrant exercise The amount represents the net proceeds from warrant exercise. Number of warrants that Shareholder agreed to exercise Number of warrants that Shareholder agreed to exercise Employment expenses Employee Compensation Expense Amount of employee compensation expense, including salaries, wages and related employment costs, excluding share-based compensation for each co-founder. Number of ordinary shares reserved under incentive plans The number of Ordinary Shares reserved under the 2024 Incentive Plan as of September 9,2025 Gross proceeds before placement agent fees Aggregate gross proceeds from the July 31, 2026 private placement, before deducting placement agent fees and other offering expenses. Additional increase in the number of Ordinary Shares, reserved for issuance under incentive plan The additional increase in the number of Ordinary Shares, reserved for issuance under the 2024 Incentive Plan. Fair value per RSU The fair value of each RSU as of the grant date. Option expenses Total expected share-based compensation expense related to the December 23, 2025, RSU grant. Equity issuance cost Incremental fair value resulting from the modification of the exercise price of previously issued warrants, accounted for as an equity issuance cost. Number of Ordinary Shares issued upon the exercise of pre-funded warrants Number of Ordinary Shares issued upon the exercise of pre-funded warrants. Number of Ordinary Shares issued upon the exercise of warrants Number of Ordinary Shares issued upon the exercise of warrants on September 16, 2022. Issued and sold ordinary shares Number of Ordinary Shares and ordinary share equivalents issued and sold in the July 31, 2026 private placement. Warrants issued in Private Placement Number of warrants issued in the July 31, 2026 private placement. Exercise price per shares Exercise price per share or per unit of warrants or rights outstanding before amendment Number of shares issued in connection with registered direct offering Number of shares issued in connection with registered direct offerings. Exercise price per ordinary shares Exercise price per ordinary shares. Number of warrants/ options | shares Number of Shares Authorized for Issuance Under the IPO Warrants Exercise Number of shares authorized for issuance under the IPO warrants exercise. Warrant reduced exercise price Warrant reduced exercise price. Warrant exercised ordinary shares Warrant exercised ordinary shares. Purchase of ordinary shares Purchase of ordinary shares. Number of warrants/ options | shares Number of Shares Authorized For Issuance Number of warrants issued in September 2022 to the legal advisor. Number of warrants/ options | shares Number of Warrants Issued in April 2026 Inducement Agreement Number of warrants issued in april 2026 inducement agreement. Number of warrants/ options | shares Number of Underwriters Warrants Represent the number of underwriters warrants.